Status:
COMPLETED
Quality of Life and Participation of the Adult with Spinal Muscular Atrophy in France
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Spinal Muscular Atrophy
Eligibility:
All Genders
18-85 years
Brief Summary
Spinal muscular atrophy is a hereditary motorneuron disease caused by a mutation of the SMN1 gene, which is at the origin of a progressive limb and axial motor deficiency. It concerns 1200 individuals...
Eligibility Criteria
Inclusion
- Patient with SMA type 1, 2, 3 or 4
- ≥ 18 years old
- giving informed consent to participate to the study
- patients from the study of Dany et al "Construction of a Quality of Life Questionnaire for slowly progressive neuromuscular disease" (2015)
Exclusion
- patients who do not complete ≥ 80% of the questionnaire)-
Key Trial Info
Start Date :
October 19 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 17 2024
Estimated Enrollment :
149 Patients enrolled
Trial Details
Trial ID
NCT05366465
Start Date
October 19 2022
End Date
February 17 2024
Last Update
March 7 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Service L'Escale - Médecine Physique et de Réadaptation Pédiatrique Groupement Hospitalier Est des Hospices Civils de Lyon
Bron, Bron, France, 69500
2
VUILLEROT Carole
Bron, Bron, France, 69500